In this article, you will read about the Success Story of Kiran Mazumdar-Shaw, Who is one of the top women entrepreneurs in India. Kiran Mazumdar-Shaw is an Indian businesswoman, entrepreneur, and the founder and president of ‘Biocon Limited’. Biocon is a leading biotechnology institute based out of Bangalore. She is the author of ‘The Story of Bear’. With a capital of Rs 10,000, Kiran Mazumdar-Shaw started an enzyme manufacturer with a company in Koramangala near Bangalore starting in 1978.
Biocon Chemicals, Ireland’s partner in the project, sold its shares to Unilever shortly afterwards, and Unilever became Kiran Mazumdar-Shaw’s new partner. Kiran Mazumdar-Shaw gained a foothold with this partnership. The partnership with Unilever no longer allowed Biocon Limited to try out any other products, thus they remained a ‘One Product’ company for 25 years.
Kiran Mazumdar’s relationship with Unilever ended in 1998 and that year was also the turning point of her life. ‘Biocon Limited’ today has an estimated value of 25 billion rupees and has made a significant contribution to redesigning biotechnology in the world.
The early life of Kiran Mazumdar-Shaw –
Kiran Mazumdar-Shaw was born on March 23, 1953, in Bengaluru (Karnataka). She completed her schooling in 1968 at ‘Bishop Cotton Girls High School’, Bangalore. He completed his BSC (Zoology Hons) degree from Bangalore University in 1973. Subsequently, he received his higher education in 1975 from Ballarat College, Melbourne University (Australia) on the subject of ‘Molting and Brewing’.
During this time he worked as a trainee Malster in Carlton and United Breweries, Bruer, Barrett Brothers, and Burston, also in Melbourne. He also briefly worked as a Technical Advisor at Jupiter Breweries Limited, Kolkata, and as a Technical Manager at Standard Malting Corporation, Baroda from 1975-1977.
Kiran Mazumdar-Shaw married ‘John-Shaw’, a native of Scotland in 1998 at the age of 45, who is currently the vice-president of John-Shaw ‘Biocon Limited’.
Contribution to Biocon Ltd. –
Kiran Mazumdar-Shaw initially faced credibility difficulties in the business model at a young age and in limited circumstances took ‘Biocon Limited’ to new heights of progress and progress. ‘Biocon Limited’, a company that manufactures enzymes and exports them to the United States and Europe, became the first biotechnology company in India within a year of its founding in 1989, funded by the US for trademarked technologies. Received. In 1990, Kiran Mazumdar-Shaw built the advanced internal research program of Biocon Ltd. based on the trademarked concurrent level reduction technology. In 1997, he took initiative in the field of human health.
When Unilever agreed to sell its partnership in ‘Biocon Limited’ in 1998, it became an independent entity. Two years later, it created a bio-reactor based on its trademarked concentric matrix fermentation, named ‘Platformer TM’. Kiran Mazumdar-Shaw built the company the first fully automated submerged fermentation plant for the production of specialty pharmaceuticals. By 2003, ‘Biocon Limited’ became the first company in the world to develop human insulin.
In 2004, Kiran Mazumdar-Shaw decided to develop research programs of Biocon Limited to reach the capital market. Biocon’s IPO was subscribed over 32 times and closed on the first day with a market value of $ 1.11 billion, becoming the second Indian company to cross the $ 1 billion mark on the first day of listing. .
Contribution to the field of business
The famous England magazine ‘The Medicine Maker’ has placed Kiran Mazumdar-Shaw at number two in the list of 100 celebrities in the pharmaceutical sector. The special thing is that the magazine has ranked only Kiran Mazumdar-Shaw from India in this list.
Kiran Mazumdar-Shaw, CMD of the Indian company Biocon Ltd, is the second most powerful drug maker in the world, second only to Anthony Fauchi (Director) National Institute of Allergy and Infectious Diseases, USA.
Kiran Mazumdar-Shaw is interested in promoting biotechnology as a field and is also a member of the Advisory Council of the Department of Biotechnology, Government of India.
Contribution to the social sector
Kiran Mazumdar-Shaw started the ‘Biocon Foundation’ in 2004 to conduct education, health, sanitation, and environment programs to benefit the poor and weaker sections of the society. Under the Foundation’s ‘Micro-Health Insurance’ program, 70 thousand rural people were named.
He joined Dr. Devi Shetty in 2007. Together with Narayan Hardayal, he has set up a 1,400-bed cancer care center at the Narayana Health City campus in Bummsandra, Bangalore. It is known as Kiran Mazumdar-Shaw Cancer Center (MSCC).
Honors and Awards
Kiran Mazumdar-Shaw is currently the Chairman and Managing Director of ‘Biocon Limited’. In addition, she is also the current President of IIM Bengaluru.
He was awarded ‘Othmer Gold Medal-2014’ in Philadelphia (USA) for his special contribution to Science and Chemistry. Kiran Mazumdar-Shaw is the third woman in the world and the first woman in India to receive the ‘Othmer Gold Medal’. In 2014, Forbes magazine ranked her 92nd among the world’s most powerful women.
A major US trade publication ‘Made Aid News’ ranked Biocon 20th among biotechnology companies worldwide and 7th among the world’s largest employers in 2007-08.
He has been given the prestigious ‘Padma Shri’ award in 1989 and Padma Bhushan in 2005.
Recently, Kiran Mazumdar-Shaw has also been included in Time magazine’s list of the 100 most influential people in the world and it has been included in the Forbes list of the 100 most powerful women in the world and the top 50 women in the Financial Times business The list also includes.
For his contributions to biotechnology, his maternal institute, Ballarat University, awarded him an honorary doctorate of science in 2004, apart from this. K. K Dundee University, 2007 K. University of Glasgow in 2008 and U.P. K. 2008 also awarded him an honorary doctorate at Harriet-Watt University in Edinburgh.
We hope you have liked this article written on the “Success Story of Kiran Mazumdar Shaw”. There are so many things we can learn from her success journey. Please share this story with your friends and social media platforms. If you have any questions and suggestions you can write in the comment section.